Table 2.
Patient # | WB‐PTV max (Gy) | WB‐PTV D2% (Gy) | WB‐PTV D98% (Gy) |
WB‐PTV
|
WB‐PTV V30 (%) | HI | CI | |
---|---|---|---|---|---|---|---|---|
I | 34.6 | 32.9 | 25.7 | 31.6 | 90.1 | 0.23 | 0.95 | |
II | 35.0 | 33.2 | 25.7 | 31.8 | 90.2 | 0.24 | 0.97 | |
III | 34.8 | 33.2 | 26.1 | 31.7 | 90.3 | 0.22 | 0.94 | |
IV | 34.5 | 32.8 | 26.9 | 31.3 | 91.5 | 0.19 | 0.94 | |
V | 35.3 | 33.8 | 26.1 | 32.6 | 90.1 | 0.23 | 1.01 | |
VI | 34.7 | 32.8 | 26.4 | 31.3 | 91.0 | 0.20 | 0.95 | |
VII | 35.2 | 33.5 | 25.5 | 31.7 | 90.1 | 0.25 | 0.96 | |
VIII | 34.4 | 32.9 | 26.2 | 31.6 | 90.9 | 0.21 | 0.96 | |
IX | 35.2 | 33.6 | 25.9 | 32.1 | 90.1 | 0.24 | 0.97 | |
X | 34.8 | 33.3 | 25.7 | 31.8 | 90.2 | 0.24 | 0.94 | |
AVG | 34.9 | 33.2 | 26.0 | 31.7 | 90.5 | 0.23 | 0.96 | |
STDEV | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.02 | 0.02 |
.